Concentra Group Holdings Parent, Inc. (CON) AI Stock Analysis

• Market Cap: $2.58B
• Dividend Yield: 0.93%
• Average Volume (3M): 860.47K
• Price to Earnings (P/E): 16.3
• Beta (1Y): 0.48
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 8,758
• Sector: Services
• Sector Strength: N/A
• Industry: Medical - Equipment & Services
• EPS (TTM): 0.30
• Shares Outstanding: 128,171,950
• 10 Day Avg. Volume: 784,177
• 30 Day Avg. Volume: 860,470
• PEG Ratio: -2.39
• Price to Book (P/B): 8.29
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 14.40
• Enterprise Value/Market Cap: 1.18
• Enterprise Value/Revenue: 0.83
• Enterprise Value/Gross Profit: 27.68
• Enterprise Value/Ebitda: 4.51
• 1Y Price Target: $27.50
• Price Target Upside: 36.14% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 63 Neutral
• Price Target: $21.00 ▲(3.96%Upside)

Concentra Group Holdings Parent, Inc. has a moderate overall stock score. The company's strong financial performance and strategic corporate events are positive factors. However, the bearish technical indicators and high financial leverage pose risks. Valuation remains fair, offering a balanced investment opportunity.

Positive Factors

Acquisitions

The integration of the Nova acquisition is progressing well and exceeding synergy targets, contributing positively to revenue.

Earnings

Q1 results were ahead of consensus estimates, showcasing strong performance despite market challenges.

Negative Factors

Employer Services

CON continues to face challenges from lower employer services volumes, as hiring and quitting rates remain low.

Volume Pressures

CON continues to face volume pressures, with total patient visits of ~2.995mm, slightly below consensus of ~3.000mm, and visits per day of 46.8k, a -2.1% decrease y/y.

Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model

Company Description

Concentra Group Holdings Parent, Inc. (CON) is a prominent player in the healthcare services sector, specializing in occupational health. The company operates a network of medical centers and onsite clinics across the United States, offering a comprehensive range of services including urgent care, physical therapy, injury care, and wellness programs. Concentra's core mission is to improve the health of America's workforce, providing tailored healthcare solutions to employers and employees alike.

How the Company Makes Money

Concentra generates revenue primarily through the provision of occupational health services to businesses and individuals. Key revenue streams include fees for medical consultations, treatment procedures, and physical therapy services rendered at their clinics. The company also leverages contracts with businesses to provide employee health programs, which include preventive care, injury management, and wellness initiatives. Additionally, Concentra partners with various insurance providers to offer covered services to insured patients. These strategic partnerships and contracts with corporate clients significantly contribute to its earnings.

Concentra Group Holdings Parent, Inc. Financial Statement Overview

Summary

Concentra Group Holdings Parent, Inc. demonstrates strong revenue growth and operational efficiency, as evidenced by healthy EBIT and EBITDA margins. However, the high debt-to-equity ratio raises concerns about financial risk, despite strong return on equity. The company shows robust cash flow generation, but the reliance on debt financing could impact long-term stability.

Income Statement

Concentra Group Holdings Parent, Inc. shows a solid financial performance with a consistent revenue growth rate of 3.38% from 2023 to 2024. The gross profit margin improved to 27.78% in 2024, indicating efficient cost management. However, the net profit margin decreased slightly to 8.76%, reflecting increased expenses or interest costs. The EBIT and EBITDA margins are strong at 16.03% and 19.38%, respectively, showcasing operational efficiency.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 7.08 in 2024, indicating significant leverage, which could pose financial risk. The return on equity (ROE) is 60.42%, demonstrating strong profitability relative to equity. However, the equity ratio is low at 10.93%, suggesting limited financial stability and reliance on debt financing.

Cash Flow

The cash flow statement highlights a robust free cash flow growth rate of 27.45% from 2023 to 2024, indicating improved cash generation. The operating cash flow to net income ratio is 1.65, suggesting efficient conversion of income to cash. However, the free cash flow to net income ratio is 1.26, reflecting moderate cash flow relative to net income.

Breakdown	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	1.90B	1.84B	1.72B
Gross Profit	527.98M	439.38M	408.19M
EBITDA	368.26M	360.15M	330.20M
Net Income	166.54M	179.95M	166.73M
Balance Sheet
Total Assets	2.52B	2.33B	2.30B
Cash, Cash Equivalents and Short-Term Investments	183.25M	31.37M	37.66M
Total Debt	1.95B	905.00M	1.04B
Total Liabilities	2.22B	1.16B	1.30B
Stockholders Equity	275.67M	1.16B	973.32M
Cash Flow
Free Cash Flow	210.35M	164.98M	228.35M
Operating Cash Flow	274.68M	234.32M	274.34M
Investing Cash Flow	-71.27M	-75.31M	-50.93M
Financing Cash Flow	-51.53M	-165.29M	-216.68M

Concentra Group Holdings Parent, Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 20.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Neutral. The current price of 20.2 is above the 20-day moving average (MA) of 20.11, below the 50-day MA of 20.95, and below the 200-day MA of 21.14, indicating a neutral trend. The MACD of -0.28 indicates Negative momentum. The RSI at 48.48 is Neutral, neither overbought nor oversold. The STOCH value of 55.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CON.

Concentra Group Holdings Parent, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LH	75 Outperform	$21.91B	28.86	9.27%	1.10%	7.98%	72.22%
CON	63 Neutral	$2.58B	16.31	20.83%	0.93%	―	―
NVST	57 Neutral	$3.52B	―	-31.33%	―	-2.30%	-854.21%
Sector *	54 Neutral	$1.84B	-19.52	7.68%	2.69%	10.18%	-64.59%
NEUE	44 Neutral	$60.48M	―	84.03%	―	-17.91%	83.17%

Concentra Group Holdings Parent, Inc. Corporate Events

Concentra Group Appoints New Board Members for Growth

On June 26, 2025, Concentra Group Holdings Parent, Inc. announced the appointment of Vipin Gopal and Brigid Bonner to its Board of Directors, effective July 1, 2025. This strategic move is aimed at enhancing the company’s growth and shareholder value by leveraging the new directors’ expertise in data, technology, and business transformation. Vipin Gopal brings extensive experience in data and AI strategy from roles at major companies like Eli Lilly and Walgreens Boots Alliance, while Brigid Bonner offers a wealth of knowledge in strategic planning and digital transformation from her leadership roles in various sectors. The appointments are expected to strengthen Concentra’s position in the healthcare industry as it navigates technological advancements and complex market dynamics.

The most recent analyst rating on (CON) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Completes Acquisition of Onsite Innovations

On June 1, 2025, Concentra Health Services, a subsidiary of Concentra Group Holdings Parent, Inc., completed the acquisition of Onsite Innovations for $55 million. This acquisition doubles the size of Concentra’s Onsite Health segment and aligns with its growth strategy, expanding its reach to approximately 350 onsite health clinics across over 40 states. The integration aims to enhance service offerings and maintain high-quality care, with key leaders from Onsite Innovations joining Concentra to ensure business continuity and growth.

The most recent analyst rating on (CON) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Group Reports Q1 2025 Financial Results

On May 7, 2025, Concentra Group Holdings Parent, Inc. announced its financial results for the first quarter ended March 31, 2025, reporting a revenue increase of 7.1% to $500.8 million and an adjusted EBITDA growth of 6.8% to $102.7 million. The company declared a cash dividend of $0.0625 per share and completed the acquisition of Nova Medical Centers, enhancing its network with 67 additional centers. Concentra also signed an agreement to acquire Pivot Onsite Innovations, which will expand its onsite health clinic footprint significantly. Despite a decrease in net income due to higher interest expenses, the company raised its financial guidance for 2025, expecting revenue between $2.1 billion and $2.15 billion.